Since PHD3 protein was undetectable in 88 ccRCC tumors (Figure 1A and C), we have investigated the expression of PHD 2/3 mRNA and protein in selected clinical samples and ccRCC cell lines. The gene discussed is EGLN3; the disease is nonpapillary renal cell carcinoma.